Canadian doctors urge caution after FDA approves controversial new opioid pill

Dsuvia tablet and applicator

After the FDA’s controversial approval of a pill form of sufentanil for use in U.S. hospitals and on the battlefield, Canadian doctors say the risks of the oral medication could outweigh the benefits in the midst of the ongoing opioid crisis.

Please follow and like us:

Related posts